Invega withdrawal symptoms typically begin within four weeks of stopping the medication and last one to four weeks for most people, though some symptoms can persist for months. The timeline varies significantly depending on which formulation you were taking, because the drug leaves your body at very different rates depending on whether you used oral tablets or one of the long-acting injections.
Why the Formulation Changes Everything
Paliperidone, the active ingredient in Invega, comes in forms that range from a daily pill to an injection given every six months. Each version has a dramatically different half-life, which is the time it takes for half the drug to clear your body. For the monthly injection (Sustenna), the half-life is 25 to 49 days. For the every-three-month injection (Trinza), it’s 84 to 95 days. And for the twice-yearly injection (Hafyera), it’s 148 to 159 days.
A drug is generally considered fully cleared after about five half-lives. That means the monthly injection can linger in your system for roughly four to eight months after your last shot. The six-month injection can take over two years to fully clear. Oral paliperidone has a much shorter half-life of about 23 hours, so it leaves your body within a few days.
This slow release from injectable formulations acts as a built-in taper. Your brain experiences a gradual reduction in the drug rather than a sudden drop. That’s why withdrawal symptoms from long-acting injections often appear later and may be milder initially, but the overall adjustment period stretches much longer than it does with oral tablets.
General Withdrawal Timeline
Research on antipsychotic withdrawal shows a fairly consistent pattern. For oral formulations, symptoms usually start within days of the last dose and can begin within four weeks for any formulation. Most withdrawal effects subside within one to four weeks of onset. However, certain movement-related symptoms, particularly a restless, jittery feeling in the muscles called hyperkinesia, can last for months.
For the long-acting injections, the timeline is harder to pin down precisely because the drug continues releasing into your bloodstream long after the last injection. You may not notice withdrawal effects for weeks or even months. When symptoms do appear, they follow a similar pattern of peaking and then gradually improving, but the entire process is stretched across a longer window. Some people on the six-month injection report feeling effects many months after their final dose as drug levels slowly decline.
What Withdrawal Feels Like
A large survey of 585 people who stopped antipsychotic medications found that 72% experienced what researchers call “classical withdrawal effects,” the same kinds of symptoms seen when stopping other medications that act on the brain. The most commonly reported symptoms paint a picture of both physical and emotional disruption.
Insomnia was the single most common complaint, reported by roughly one in five respondents. Anxiety and nervousness were next, followed by extreme or rapidly shifting emotions, including mood swings, episodes of euphoria, and intense emotionality that felt out of proportion to circumstances. Many people described unexplained crying spells.
Physical symptoms included nausea and vomiting, dizziness, headaches, body aches, tremors, sweating (including night sweats), and heart palpitations. Some people reported “brain zaps,” brief electrical-sensation feelings in the head, as well as heightened sensitivity to light and sound, vivid or bizarre dreams, and cognitive difficulties like trouble concentrating or memory problems.
On the psychological side, depression, irritability, anger, agitation, and suicidal thoughts were all reported. About 18% of respondents experienced psychotic symptoms during withdrawal, including hallucinations, paranoia, and delusions. This is a critical distinction to understand, because not all psychosis during withdrawal means your original condition is returning.
Withdrawal Psychosis vs. Relapse
When antipsychotics block dopamine receptors over time, the brain compensates by increasing both the number and sensitivity of those receptors. When the drug is removed, the brain is temporarily flooded with dopamine activity it can’t regulate properly. This can produce psychotic symptoms that look identical to the condition the drug was prescribed to treat, but are actually a withdrawal reaction.
Researchers have noted that the way someone stops the medication matters. Abrupt discontinuation produces more psychotic episodes than gradual tapering, which strongly suggests that at least some of these episodes are withdrawal effects rather than true relapse. The destabilization caused by other withdrawal symptoms, particularly insomnia, anxiety, and agitation, can also trigger genuine relapse in vulnerable people. Distinguishing between these scenarios is difficult even for clinicians, but the pattern matters: withdrawal psychosis tends to emerge relatively soon after stopping and may resolve on its own, while a true relapse of the underlying condition typically follows a different course.
Factors That Affect How Long It Lasts
Several variables influence both the severity and duration of your withdrawal experience. The most significant is how long you took the medication. Research using a nationwide patient cohort found a striking relationship: people who stopped antipsychotics soon after first starting them had only a small increased risk of relapse, but the risk doubled after one to two years of use, tripled after two to five years, and increased sevenfold after eight or more years. Longer exposure gives the brain more time to adapt to the drug’s presence, which means it needs more time to readjust without it.
Your dose also matters, particularly the size of the final “step down.” Dropping from a high dose to nothing represents a much larger shock to your dopamine system than tapering gradually from a low dose. The speed of reduction plays a role too. Abrupt discontinuation consistently produces worse outcomes than gradual tapering. For people who have been on antipsychotics for years, experts suggest tapering over months or even years, reducing to very small doses before stopping entirely.
There is also considerable individual variability. Two people on the same dose for the same duration can have very different withdrawal experiences based on their unique brain chemistry and how their receptors adapted. This makes it impossible to predict an exact timeline for any one person.
What a Realistic Timeline Looks Like
For oral Invega stopped abruptly, expect the possibility of symptoms starting within a few days, peaking in the first one to two weeks, and most physical symptoms resolving within four weeks. Sleep problems, emotional instability, and movement-related symptoms may take longer.
For the monthly injection (Sustenna), the drug’s slow elimination means symptoms may not begin for several weeks. The overall adjustment period can stretch across several months as drug levels gradually decline. For the three-month (Trinza) and six-month (Hafyera) injections, the timeline extends further still, potentially spanning many months to over a year before the drug is fully out of your system and your brain has had time to recalibrate.
Gradual tapering, when possible, tends to produce a milder and more manageable withdrawal course. For people who have taken Invega for prolonged periods, a slow reduction guided by individual response gives the brain time to gradually restore normal dopamine receptor function, rather than forcing an abrupt adjustment that can feel overwhelming.